JP2015506689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506689A5 JP2015506689A5 JP2014554824A JP2014554824A JP2015506689A5 JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5 JP 2014554824 A JP2014554824 A JP 2014554824A JP 2014554824 A JP2014554824 A JP 2014554824A JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- virus
- expression vector
- nucleotide sequence
- viral expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590070P | 2012-01-24 | 2012-01-24 | |
| US201261590056P | 2012-01-24 | 2012-01-24 | |
| US61/590,056 | 2012-01-24 | ||
| US61/590,070 | 2012-01-24 | ||
| US201261683810P | 2012-08-16 | 2012-08-16 | |
| US61/683,810 | 2012-08-16 | ||
| PCT/US2013/022962 WO2013112720A1 (en) | 2012-01-24 | 2013-01-24 | Parainfluenza virus 5 based vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017198111A Division JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506689A JP2015506689A (ja) | 2015-03-05 |
| JP2015506689A5 true JP2015506689A5 (https=) | 2016-03-10 |
| JP6228136B2 JP6228136B2 (ja) | 2017-11-08 |
Family
ID=48873896
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554824A Active JP6228136B2 (ja) | 2012-01-24 | 2013-01-24 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2017198111A Pending JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2019168928A Active JP6900437B2 (ja) | 2012-01-24 | 2019-09-18 | パラインフルエンザウイルス５型ベースのワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017198111A Pending JP2018050624A (ja) | 2012-01-24 | 2017-10-12 | パラインフルエンザウイルス５型ベースのワクチン |
| JP2019168928A Active JP6900437B2 (ja) | 2012-01-24 | 2019-09-18 | パラインフルエンザウイルス５型ベースのワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US9732358B2 (https=) |
| EP (2) | EP2806891B1 (https=) |
| JP (3) | JP6228136B2 (https=) |
| CN (2) | CN104093422B (https=) |
| AU (1) | AU2013212097B2 (https=) |
| BR (1) | BR112014018179B1 (https=) |
| CA (2) | CA3128591A1 (https=) |
| ES (1) | ES2728248T3 (https=) |
| MX (1) | MX359638B (https=) |
| MY (1) | MY173638A (https=) |
| PH (1) | PH12014501255B1 (https=) |
| PT (1) | PT2806891T (https=) |
| WO (2) | WO2013112720A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3123276A1 (en) | 2011-02-25 | 2012-08-30 | University Of Georgia Research Foundation, Inc. | Recombinant mumps virus vaccine |
| ES2728248T3 (es) | 2012-01-24 | 2019-10-23 | Univ Georgia | Vacunas basadas en el virus paragripal 5 |
| KR101577397B1 (ko) * | 2014-01-15 | 2015-12-28 | 경북대학교 산학협력단 | 신규한 돼지 파라인플루엔자 바이러스 5(pPIV5), 이를 포함하는 백신 조성물 및 이를 이용한 돼지 파라인플루엔자 바이러스 검정 키트 |
| CN107847610B (zh) * | 2015-04-28 | 2022-02-01 | 塞维卡有限责任公司 | 基于piv5的扩增病毒样颗粒 |
| JPWO2016199936A1 (ja) * | 2015-06-12 | 2018-04-05 | 国立大学法人三重大学 | ヒトパラインフルエンザ２型ウイルスベクター及びワクチン |
| EP3630144A4 (en) * | 2017-05-25 | 2021-03-31 | University of Central Florida Research Foundation, Inc. | NEW ONCOLYTIC VIRUSES TO SENSITIZE TUMOR CELLS TO DESTRUCTION BY NATURAL KILLER CELLS |
| RU2681473C1 (ru) * | 2018-01-16 | 2019-03-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Тест-система для обнаружения генома вируса парагриппа 3 типа у крупного рогатого скота с помощью мультиплексной полимеразной цепной реакции с флуоресцентной детекцией в режиме реального времени |
| GB201816873D0 (en) * | 2018-10-17 | 2018-11-28 | Imperial Innovations Ltd | Fusion protein |
| WO2020092207A1 (en) * | 2018-10-28 | 2020-05-07 | University Of Georgia Research Foundation | Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof |
| CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
| JP7802064B2 (ja) * | 2020-09-21 | 2026-01-19 | ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド | Ｐｉｖ５ベースのｃｏｖｉｄ－１９ワクチン |
| US20240102912A1 (en) * | 2020-11-09 | 2024-03-28 | Thrive Bioscience, Inc. | Plaque counting assay method |
| CN113005149A (zh) * | 2021-03-26 | 2021-06-22 | 中国农业大学 | 一种表达冠状病毒受体结合域串联二聚体的重组副流感病毒5型载体 |
| CA3230325A1 (en) * | 2021-08-26 | 2023-03-02 | University Of Georgia Research Foundation, Inc. | J paramyxovirus vaccines |
| GB202209861D0 (en) * | 2022-07-05 | 2022-08-17 | Univ Court Univ St Andrews | Viral vectors |
| EP4611804A1 (en) * | 2022-11-04 | 2025-09-10 | Blue Lake Biotechnology, Inc. | Recombinant rsv vaccine: methods of making and using the same |
| CN121263205A (zh) * | 2023-02-06 | 2026-01-02 | 塞维卡有限责任公司 | 修饰的piv5疫苗载体：制造方法和用途 |
| CN116270766A (zh) * | 2023-02-23 | 2023-06-23 | 天津理工大学 | 一种副流感病毒5型作为溶瘤病毒在抗肿瘤中的应用 |
| CN117625560B (zh) * | 2023-11-03 | 2025-09-16 | 中国农业大学 | 一种重组病毒rPIV5-H3及其制备方法、应用和疫苗 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
| CA2160038A1 (en) * | 1995-07-14 | 1997-01-15 | Biosignal Inc. | Methods of screening compounds for their pharmacological relevance based on downregulation of recombinant receptors |
| EP0906442A1 (en) | 1996-05-01 | 1999-04-07 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services | Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
| US6410023B1 (en) * | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| US5962274A (en) | 1998-03-13 | 1999-10-05 | Wake Forest University | Viral vector directed to predetermined target cells |
| AU785148B2 (en) | 1999-12-10 | 2006-10-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| US6764685B1 (en) * | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| JP2002153278A (ja) | 2000-11-22 | 2002-05-28 | Hisamitsu Pharmaceut Co Inc | ウイルスベクターの製造に用いられる細胞、その製法およびその細胞を用いたウイルスベクターの製造方法 |
| US20050048030A1 (en) | 2001-09-28 | 2005-03-03 | Raymond Pickles | Paramyxoviruses as gene transfer vectors to lung cells |
| US7585667B2 (en) | 2003-06-13 | 2009-09-08 | The United States Of America As Represented By The Department Of Health And Human Services | Negative strand RNA virus replicon |
| US20110008838A1 (en) | 2007-07-19 | 2011-01-13 | Gale Smith | Chimeric varicella zoster virus virus-like particles |
| US20090208495A1 (en) * | 2008-02-14 | 2009-08-20 | Bayer Schering Pharma Ag | Anti-tumor effective paramyxovirus |
| FR2938840B1 (fr) | 2008-11-21 | 2010-12-17 | Centre Nat Rech Scient | Proteines mutantes de la proteine f de piv-5 et de piv-2 |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| ES2728248T3 (es) | 2012-01-24 | 2019-10-23 | Univ Georgia | Vacunas basadas en el virus paragripal 5 |
-
2013
- 2013-01-24 ES ES13741216T patent/ES2728248T3/es active Active
- 2013-01-24 MY MYPI2014702016A patent/MY173638A/en unknown
- 2013-01-24 US US14/374,070 patent/US9732358B2/en active Active
- 2013-01-24 EP EP13741216.9A patent/EP2806891B1/en active Active
- 2013-01-24 AU AU2013212097A patent/AU2013212097B2/en active Active
- 2013-01-24 WO PCT/US2013/022962 patent/WO2013112720A1/en not_active Ceased
- 2013-01-24 CA CA3128591A patent/CA3128591A1/en active Pending
- 2013-01-24 MX MX2014008557A patent/MX359638B/es active IP Right Grant
- 2013-01-24 PT PT13741216T patent/PT2806891T/pt unknown
- 2013-01-24 JP JP2014554824A patent/JP6228136B2/ja active Active
- 2013-01-24 US US14/374,061 patent/US9505807B2/en active Active
- 2013-01-24 CA CA2860388A patent/CA2860388C/en active Active
- 2013-01-24 WO PCT/US2013/022898 patent/WO2013112690A1/en not_active Ceased
- 2013-01-24 CN CN201380006495.2A patent/CN104093422B/zh active Active
- 2013-01-24 EP EP19165071.2A patent/EP3536341A1/en active Pending
- 2013-01-24 CN CN201810061733.4A patent/CN108130345A/zh active Pending
- 2013-01-24 BR BR112014018179-9A patent/BR112014018179B1/pt active IP Right Grant
-
2014
- 2014-06-04 PH PH12014501255A patent/PH12014501255B1/en unknown
-
2016
- 2016-10-18 US US15/296,346 patent/US10752916B2/en active Active
-
2017
- 2017-06-30 US US15/638,946 patent/US10329585B2/en active Active
- 2017-10-12 JP JP2017198111A patent/JP2018050624A/ja active Pending
-
2019
- 2019-05-24 US US16/421,837 patent/US20190284578A1/en not_active Abandoned
- 2019-09-18 JP JP2019168928A patent/JP6900437B2/ja active Active
-
2020
- 2020-08-10 US US16/989,038 patent/US11542527B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015506689A5 (https=) | ||
| Imai et al. | The role of receptor binding specificity in interspecies transmission of influenza viruses | |
| Bouvier et al. | The biology of influenza viruses | |
| Cheung et al. | Biology of influenza a virus | |
| JP2014504500A5 (https=) | ||
| US8828406B2 (en) | Influenza viruses and uses thereof | |
| Neumann et al. | Reverse genetics of influenza virus | |
| Gambotto et al. | Human infection with highly pathogenic H5N1 influenza virus | |
| US9217157B2 (en) | Recombinant influenza viruses and uses thereof | |
| CA2631812C (en) | Chimeric viruses presenting non-native surface proteins and uses thereof | |
| JP5491173B2 (ja) | イヌ細胞中でマイナス鎖ウイルスｒｎａを発現させるための方法および組成物 | |
| US20190125859A1 (en) | Influenza virus vaccination regimens | |
| RU2013135498A (ru) | Экспрессионные системы | |
| WO2008147496A2 (en) | Neuraminidase-deficient live influenza vaccines | |
| Neumann et al. | Generation of influenza A virus from cloned cDNAs—historical perspective and outlook for the new millenium | |
| WO2021081120A1 (en) | Recombinant neuraminidase and uses thereof | |
| Ye et al. | Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses | |
| Steel | New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges | |
| Hatta et al. | Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection | |
| Ye et al. | Influenza reverse genetics: dissecting immunity and pathogenesis | |
| CN104704112A (zh) | 传染性流感病毒的生产 | |
| Chang et al. | Avian influenza virus: the threat of a pandemic | |
| JP2017531032A (ja) | ワクチン抗原の製造方法、得られるワクチン抗原、および使用 | |
| Finch et al. | Design of alternative live attenuated influenza virus vaccines | |
| Mara et al. | Investigating the interaction between negative strand rna viruses and their hosts for enhanced vaccine development and production |